Skip to main content
. 2020 Dec 25;10(1):48. doi: 10.3390/jcm10010048

Table 2.

Comparison between GEFC and REFC intensity values in eyes with and without diabetic macular edema.

Macular Sector
(ETDRS Grid)
DME (no = 0/yes = 1) GEFC Intensity p Value * REFC Intensity p Value *
Fovea 0
1
17.4 ± 14.1
43.3 ± 21.2
<0.001 ** 18.5 ± 12.6
47.1 ± 21.4
<0.001 **
Nasal 1.5 mm 0
1
52.2 ± 25.9
54.7 ± 21.2
0.66 62 ± 23.3
62.7 ± 21.1
0.90
Nasal 3 mm 0
1
74.9 ± 23.5
68.5 ± 15.4
0.35 96.4 ± 25.3
88.6 ± 17.3
0.30
Superior 1.5 mm 0
1
53.2 ± 19.3
52 ± 21.6
0.38 64.2 ± 19.7
61 ± 21.7
0.44
Superior 3 mm 0
1
87.9 ± 21.9
75.2 ± 25.3
0.03 ** 111.7 ± 26.7
89.2 ± 23.7
0.001 **
Inferior 1.5 mm 0
1
55.2 ± 18.4
53.7 ± 15.2
0.66 73.5 ± 79.8
62.5 ± 16.5
0.42
Inferior 3 mm 0
1
78.5 ± 20.6
74.7 ± 20.7
0.43 104.4 ± 88.9
93.2 ± 6.1
0.58
Temporal 1.5 mm 0
1
55.9 ± 19.7
50.7 ± 19.4
0.11 65.9 ± 19.8
60.3 ± 19.4
0.10
Temporal 3 mm 0
1
78.4 ± 21.8
64.9 ± 23.6
0.004 ** 95 ± 23.1
79.4 ± 26.3
0.002 **

* Two-sided unpaired t-test: comparison between patients with and without DME in nine different sectors of a standard 6-mm ETDRS grid. Statistical significance was set at p = 0.05. ** Comparisons that reached statistical significance. Values are reported as mean ± SD. DME: diabetic macular edema; GEFC: green emission fluorescence component; REFC: red emission fluorescence component; SD: standard deviation; ETDRS: early treatment diabetic retinopathy study.